# To Investigate the Pharmacokinetics of EPORON® and EPREX® After Subcutaneous Administration in Healthy Male Volunteers

> **NCT02580006** · PHASE1 · UNKNOWN · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 42 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** EPORON
- **DRUG:** EPREX

## Key facts

- **NCT ID:** NCT02580006
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2016-01
- **Final completion:** 2016-03
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2015-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02580006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02580006, "To Investigate the Pharmacokinetics of EPORON® and EPREX® After Subcutaneous Administration in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02580006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*